This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Orbsen Therapeutics Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Lisa O'Flynn
Introduction
Lisa O'Flynn is a prominent inventor based in Galway, Ireland. She has made significant strides in the field of stem cell research, particularly with her innovative methods for isolating stromal stem cells. Her work has the potential to impact various medical applications and therapies.
Latest Patents
O'Flynn holds a patent titled "Methods of isolation and use of CD39 stromal stem cells." This patent discloses methods for isolating SDC2+ stromal stem cells through the expression of the surface marker CD39. Additionally, it includes details about the stromal stem cells that are isolated using these methods. She has 1 patent to her name, showcasing her contributions to the field.
Career Highlights
Lisa O'Flynn is associated with Orbsen Therapeutics Limited, where she continues to advance her research and innovations. Her work at the company focuses on developing therapeutic solutions that leverage her expertise in stem cell technology.
Collaborations
O'Flynn collaborates with notable colleagues, including Stephen Joseph Elliman and Jack Kavanaugh. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in the field of stem cell research.
Conclusion
Lisa O'Flynn's innovative work in isolating stromal stem cells positions her as a key figure in the field of regenerative medicine. Her contributions through her patent and collaborations reflect her commitment to advancing scientific knowledge and therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile